Impact of Pneumococcal Conjugate Vaccine Immunization on Nasopharyngeal Carriage of Streptococcus pneumoniae in Vaccinated Children Under 5 Years Old in El Salvador

肺炎球菌结合疫苗免疫接种对萨尔瓦多5岁以下接种疫苗儿童鼻咽部肺炎链球菌携带率的影响

阅读:2

Abstract

BACKGROUND: Following pneumococcal conjugate vaccine (PCV) introduction in El Salvador, data on pneumococcal nasopharyngeal (NP) carriage in children are limited. This study assessed NP carriage of Streptococcus pneumoniae in healthy Salvadoran children aged 1-4 years to evaluate the impact of different vaccine schedules (PCV10, PCV13, or PCV10 plus PCV13). METHODS: In this analytical cross-sectional study, 380 fully vaccinated children attending well-child visits were enrolled over 1 year. Nasopharyngeal swabs were collected to determine S. pneumoniae carriage prevalence, serotype distribution, antimicrobial susceptibility, and associated risk factors. RESULTS: Overall carriage prevalence was 14.2%. Carriage was 3 times higher in children receiving PCV10 alone compared to PCV13 alone (adjusted odds ratio [aOR] 3.0, 95% CI 1.5-6.1). No carriers were identified in the PCV10 + PCV13 group. The most frequent serotype was 22F (non-vaccine type), followed by 23B, 19F, and 19Fv. Only 22% of isolated serotypes were covered by available PCVs. Significant risk factors for carriage included younger age (1 year; aOR 2.8, 95% CI 1.4-5.6) and maternal education below high school level (aOR 2.2, 95% CI 1.1-4.3). Carriage decreased significantly with increasing age. Isolates showed high sensitivity to penicillin and other common antibiotics. CONCLUSIONS: Vaccine type significantly influences NP carriage. The predominance of non-vaccine serotypes and lower carriage with PCV13 and mixed schedules highlights the need for ongoing serotype surveillance to update national immunization strategies and optimize protection against pneumococcal disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。